Glaxo SmithKline
Last Updated:
- 43.11 EGP
- -0.47
- -1.08%
جلاكسو سميثكلاين
جلاكسو سميثكلاين
Symbol :
BIOC
ISIN :
EGS38171C012
52-Week Range :
24.70
-
47.50
Turnover Ratio :
0.25
Market :
Egyptian Exchange
Sector :
Real Estate
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Top News
- A 19-August GSK Egypt’s net profits hike in H1-24
- B 15-May GSK Egypt turns to loss in Q1-24
- C 30-April GSK Egypt obtains shareholders’ nod for 2023 cash dividends
- D 04-March GSK Egypt’s consolidated profits plunge to EGP 60m in 2023; dividends approved
- E 19-November GSK Egypt records plunge in 9M-23 profits; sales hit EGP 1.57bn
- F 16-August GSK Egypt’s net profits shrink in H1-23 results
- G 01-June GSK Egypt generates lower consolidated profits in Q1-23
- H 04-May GSK Egypt’s shareholders approve 2022 cash dividends
- I 03-April GSK Egypt records 376% leap in 2022 consolidated profits; dividends announced
- J 30-November GSK Egypt sees surge in 9M-22 consolidated profits
- K 17-November GSK Egypt posts higher standalone profits at EGP 930m in 9M-22
- L 31-August GSK Egypt’s profits climb to EGP 872m in H1-22
